BioAtla (BCAB) Treasury Shares (2020 - 2026)

BioAtla's Treasury Shares history runs 7 years deep, the most recent figure standing at $59740.0 for Q1 2026.

• On a quarterly basis, Treasury Shares fell 97.95% year-over-year to $59740.0 in Q1 2026; TTM through Mar 2026 was $59740.0, a 97.95% decrease from a year earlier, with the FY2025 full-year figure at $48676.0, down 96.87% from the prior year.
• Treasury Shares rose to $59740.0 in Q1 2026 per BCAB's latest filing, from $48676.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $2.9 million in Q1 2025 and bottomed at $48676.0 in Q4 2025.
• The 5-year median for Treasury Shares is $739959.0 (2022), against an average of $1.1 million.
• Across the five-year window, Treasury Shares soared 1467.04% in 2024 and slumped 97.95% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $510039.0 in 2022, then plunged by 80.57% to $99104.0 in 2023, then surged by 1467.04% to $1.6 million in 2024, then sank by 96.87% to $48676.0 in 2025, then rose by 22.73% to $59740.0 in 2026.
• Per Business Quant, the three latest BCAB Treasury Shares figures stand at $59740.0 (Q1 2026), $48676.0 (Q4 2025), and $2.5 million (Q3 2025).